Related Experiment Video
Updated: Jun 24, 2026
08:17
VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance
Published on: August 23, 2013
Genes conferring specific plant disease resistance
Science (New York, N.Y.)
|January 28, 1972
Summary
Researchers studied host resistance genes in flax using a modified cis-trans test. Findings reveal gene interactions within complex loci, impacting host-parasite relationships.
Area of Science:
- Genetics
- Plant Pathology
- Molecular Biology
Background:
- Complex loci containing host resistance genes offer insights into gene structure and function.
- Understanding gene interactions is crucial for deciphering specific host-parasite relationships.
Purpose of the Study:
- To investigate the position effects of codominant resistance genes within complex loci in flax.
- To analyze gene interactions and their structural implications using a modified cis-trans test.
Main Methods:
- Utilized a modified cis-trans test on F(2) segregants in flax.
- Employed a specially developed analytical method to interpret gene behavior within two complex loci (M and L).
- Operationally defined resistance genes to facilitate analysis.
Main Results:
- Observed differential behavior of genes within the M and L complex loci.
- Interpreted position effects of codominant genes based on their interactions and recombination.
- Identified potential structural differences between gene groups.
Conclusions:
- The distinct behavior of genes in M and L groups suggests structural variations.
- These structural differences have significant implications for the theory of specific host-parasite interactions.
- Further research into gene structure can refine our understanding of plant-pathogen dynamics.
Related Concept Videos
00:53Transgenic Organisms
Overview
01:59Plant Breeding and Biotechnology
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
02:50Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...